Construction and validation of an immunoediting-based optimized neoantigen load (ioTNL) model to predict the response and prognosis of immune checkpoint therapy in various cancers.
Phase and context shape the function of composite oncogenic mutations.
Nature
Gorelick, Alexander N AN; Sánchez-Rivera, Francisco J FJ; Cai, Yanyan Y; Bielski, Craig M CM; Biederstedt, Evan E; Jonsson, Philip P; Richards, Allison L AL; Vasan, Neil N; Penson, Alexander V AV; Friedman, Noah D ND; Ho, Yu-Jui YJ; Baslan, Timour T; Bandlamudi, Chaitanya C; Scaltriti, Maurizio M; Schultz, Nikolaus N; Lowe, Scott W SW; Reznik, Ed E; Taylor, Barry S BS
Martelotto, Luciano G LG; Ng, Charlotte Ky CK; De Filippo, Maria R MR; Zhang, Yan Y; Piscuoglio, Salvatore S; Lim, Raymond S RS; Shen, Ronglai R; Norton, Larry L; Reis-Filho, Jorge S JS; Weigelt, Britta B
Pleomorphic liposarcoma: clinical observations and molecular variables.
Cancer
Ghadimi, Markus P MP; Liu, Ping P; Peng, Tingsheng T; Bolshakov, Svetlana S; Young, Eric D ED; Torres, Keila E KE; Colombo, Chiara C; Hoffman, Aviad A; Broccoli, Dominique D; Hornick, Jason L JL; Lazar, Alexander J AJ; Pisters, Peter P; Pollock, Raphael E RE; Lev, Dina D
Effects of p53 mutants derived from lung carcinomas on the p53-responsive element (p53RE) of the MDM2 gene.
British Journal Of Cancer
Gorgoulis, V G VG; Zacharatos, P V PV; Manolis, E E; Ikonomopoulos, J A JA; Damalas, A A; Lamprinopoulos, C C; Rassidakis, G Z GZ; Zoumpourlis, V V; Kotsinas, A A; Rassidakis, A N AN; Halazonetis, T D TD; Kittas, C C